Drug Profile
Molgramostim biosimilar - Amoytop Biotech
Alternative Names: rHuGM-CSF - Xiamen Amoytop Biotech; TopleuconLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Xiamen Amoytop Biotech
- Class Antibacterials; Antibronchitics; Antifibrotics; Antineoplastics; Chemoprotectants; Immunotherapies; Recombinant proteins
- Mechanism of Action Granulocyte-macrophage colony stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Agranulocytosis